Development
Sanofi
SNY
$48.22
-$1.19-2.41%
NASDAQ
| 12/31/2023 | 06/30/2023 | 12/31/2022 | 09/30/2022 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 9.63B | 8.73B | 13.61B | -- | |
| Total Receivables | 12.20B | 9.43B | 11.48B | -- | |
| Inventory | 10.68B | 10.88B | 9.58B | -- | |
| Prepaid Expenses | 848.90M | -- | 763.07M | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | 537.19M | 3.97B | 1.02B | -- | |
| Total Current Assets | 33.90B | 33.02B | 36.46B | -- | |
|
|
|||||
| Total Current Assets | 33.90B | 33.02B | 36.46B | -- | |
| Net Property, Plant & Equipment | 13.06B | 12.58B | 12.49B | -- | |
| Long-term Investments | 54.61B | 53.76B | 53.32B | -- | |
| Goodwill | 54.61B | 53.76B | 53.32B | -- | |
| Total Other Intangibles | 20.21B | 21.13B | 16.47B | -- | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | 15.06B | 13.57B | 13.74B | -- | |
| Total Assets | 139.79B | 136.85B | 135.43B | -- | |
|
|
|||||
| Total Accounts Payable | 8.10B | 8.04B | 7.28B | -- | |
| Total Accrued Expenses | 2.76B | -- | 2.76B | -- | |
| Short-term Debt | 224.38M | 3.15B | 175.27M | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | 2.34B | 2.25B | 4.58B | -- | |
| Total Finance Division Other Current Liabilities | 13.33B | 13.63B | 10.83B | -- | |
| Total Other Current Liabilities | 13.33B | 13.63B | 10.83B | -- | |
| Total Current Liabilities | 26.76B | 27.07B | 25.62B | -- | |
|
|
|||||
| Total Current Liabilities | 26.76B | 27.07B | 25.62B | -- | |
| Long-Term Debt | 15.86B | 15.55B | 15.88B | -- | |
| Short-term Debt | 224.38M | 3.15B | 175.27M | -- | |
| Capital Leases | 1.94B | 2.01B | 2.03B | -- | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | 13.05B | 12.59B | 11.58B | -- | |
| Total Liabilities | 57.60B | 57.21B | 55.11B | -- | |
|
|
|||||
| Common Stock & APIC | 3.14B | 2.91B | 2.83B | -- | |
| Retained Earnings | -- | -- | -- | -- | |
| Treasury Stock & Other | 78.70B | 76.38B | 77.09B | -- | |
| Total Common Equity | 81.84B | 79.29B | 79.92B | -- | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | -- | -- | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | |
|
|
|||||
| Total Common Equity | 81.84B | 79.29B | 79.92B | -- | |
| Total Preferred Equity | -- | -- | -- | -- | |
| Total Minority Interest | 345.97M | 347.16M | 393.29M | -- | |
| Total Equity | 82.19B | 79.64B | 80.32B | -- | |
|
|
|||||